DLBCL Infopoint

Dear colleagues!
after exciting ASH 2021 and EHA 2022 annual congresses and fundamental updates in the field of DLBCL, the idea was born to organize a preceptorship-meeting at University Hospital Würzburg (UKW). German and international colleagues discussed the changed DLBCL landscape and arising implications. Our main scientific objectives were:

Discussion of the updated DLBCL treatment landscape
Exchange of “hands on experience” regarding novel therapies under peers
Increase of awareness of novel treatment-sequencing modalities within the community.

We are happy to let you re-live the meeting via our on-demand videos
Best regards,

Johannes Düll, Senior physician
Universitätsklinik Würzburg

Welcome and introduction
Dr. med. Johannes Düll

DLBCL: Classification and Molecular Aspects
Prof. Dr. med. Andreas Rosenwald

DLBCL treatment landscape: where we come from
Professor Gilles Salles

DLBCL Imaging: from CT to FDG PET
Prof. Dr. med. Andreas Buck

First line DLBCL – State of the art – from EPOCH-R to Polarix
Prof. Dr. med. Peter Borchmann

CD19 a target to cure?
Dr. med. Johannes Düll

Second line DLBCL – Many options one direction?
– From R-GemOx to CAR T
Prof. Dr. med. Max Topp

Third line and beyond – from SOC to clinical trials
Prof. Dr. med. Georg Lenz

Sequencing therapies – case studies and discussion
Prof. Dr. med. Björn Chapuy
Anna Ruckdeschel

Conclusion and Farewell

Click to open Schedule

Stichwörter:

cme-kurse, cme punkte, cme kostenlos, cme online, medizinische fortbildung, cme-kurs, cme kurs online, cme-kurs online, cme-kurs arzt, cme kurs arzt, cme-punkte, cme-fortbildung kostenlos, cme-punkte kostenlos

The DLBCL: New Horizons 2022 onsite meeting and live-webinar took place 28.10.2022 and 29.10.2022

Melden Sie sich jetzt für unseren Newsletter an